FDA drops Whoop warning letter over blood pressure feature

The FDA withdrew its warning letter to Whoop after the wearable device maker made modifications to its blood pressure insights feature to comply with FDA requirements for wellness devices. The resolution reflects ongoing regulatory clarity for consumer health technology.